Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2058-7716
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer ; volume:8 ; number:1 ; day:1 ; month:12 ; year:2022 ; pages:1-13 ; date:12.2022
Cell death discovery ; 8, Heft 1 (1.12.2022), 1-13, 12.2022

Creator
Xu, Zhaowei
Liu, Shuyan
Feng, Chun
Xu, Fuyi
Kong, Demin
Mi, Jia
Yang, Chunhua
Zhang, Guilong
Wei, Pengfei
Orgil, Buyan-Ochir
Bergquist, Jonas
Tian, Geng
Contributor
SpringerLink (Online service)

DOI
10.1038/s41420-022-01269-x
URN
urn:nbn:de:101:1-2023021021040432848822
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Xu, Zhaowei
  • Liu, Shuyan
  • Feng, Chun
  • Xu, Fuyi
  • Kong, Demin
  • Mi, Jia
  • Yang, Chunhua
  • Zhang, Guilong
  • Wei, Pengfei
  • Orgil, Buyan-Ochir
  • Bergquist, Jonas
  • Tian, Geng
  • SpringerLink (Online service)

Other Objects (12)

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Metastatic Triple-Negative Breast Cancer

Metastatic Triple-Negative Breast Cancer

MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2

MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2

Characterizing triple-negative breast cancer tumors

Characterizing triple-negative breast cancer tumors

Triple-Negative Breast Cancer: Multimodality Appearance

Triple-Negative Breast Cancer: Multimodality Appearance

KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer

KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer

19 F MRI/CEUS Dual Imaging‐Guided Sonodynamic Therapy Enhances Immune Checkpoint Blockade in Triple‐Negative Breast Cancer

19 F MRI/CEUS Dual Imaging‐Guided Sonodynamic Therapy Enhances Immune Checkpoint Blockade in Triple‐Negative Breast Cancer

Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer

Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer

Related objects